Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the domain of hematological malignancies. Novel treatment modalities such as targeted therapy, immunotherapies, and therapy are revolutionizing the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative techni